A Phase II trial of green tea in the treatment of patients with androgen independent metastatic prostate carcinomaJATOI, Aminah; ELLISON, Neil; FLYNN, Patrick J et al.Cancer. 2003, Vol 97, Num 6, pp 1442-1446, issn 0008-543X, 5 p.Article

Quality of life and pain in advanced stage prostate cancer : Results of a southwest oncology group randomized trial comparing docetaxel and estramustine to mitoxantrone and prednisoneBERRY, Donna L; MOINPOUR, Carol M; HUSSAIN, Maha H. A et al.Journal of clinical oncology. 2006, Vol 24, Num 18, pp 2828-2835, issn 0732-183X, 8 p.Article

Phase III evaluation of octreotide versus chemotherapy with 5-fluorouracil or 5-fluorouracil plus leucovorin in advanced exocrine pancreatic cancer : A north central cancer treatment Group studyBURCH, Patrick A; BLOCK, Margaret; KUROSS, Steven A et al.Clinical cancer research. 2000, Vol 6, Num 9, pp 3486-3492, issn 1078-0432Article

The Prognostic Value of Clinical and Pathologic Factors in Esophageal Adenocarcinoma: A Mayo Cohort of 796 Patients With Extended Follow-up After Surgical ResectionYOON, Harry H; KHAN, Maliha; QIAN SHI et al.Mayo Clinic proceedings. 2010, Vol 85, Num 12, pp 1080-1089, issn 0025-6196, 10 p.Article

Docetaxel and estramustine compared with mitoxantrone and prednisone for advanced refractory prostate cancerPETRYLAK, Daniel P; TANGEN, Catherine M; BENSON, Mitchell C et al.The New England journal of medicine. 2004, Vol 351, Num 15, pp 1513-1520, issn 0028-4793, 8 p.Article

Phase II study of paclitaxel and cisplatin for advanced urothelial cancerBURCH, Patrick A; RICHARDSON, Ronald L; CHA, Stephen S et al.The Journal of urology. 2000, Vol 164, Num 5, pp 1538-1542, issn 0022-5347Article

Phase ii evaluation of continuous-infusion 5-fluorouracil, leucovorin, mitomycin-C, and oral dipyridamole in advanced measurable pancreatic cancer a North Central Cancer Treatment Group TrialBURCH, Patrick A; GHOSH, Chirantan; COBAU, Charles D et al.American journal of clinical oncology. 2000, Vol 23, Num 5, pp 534-537, issn 0277-3732Article

Obesity Adversely Affects Survival in Pancreatic Cancer PatientsMCWILLIAMS, Robert R; MATSUMOTO, Martha E; BURCH, Patrick A et al.Cancer. 2010, Vol 116, Num 21, pp 5054-5062, issn 0008-543X, 9 p.Article

Integrated Data From 2 Randomized, Double-Blind, Placebo-Controlled, Phase 3 Trials of Active Cellular Immunotherapy With Sipuleucel-T in Advanced Prostate CancerHIGANO, Celestia S; SCHELLHAMMER, Paul F; SMALL, Eric J et al.Cancer. 2009, Vol 115, Num 16, pp 3670-3679, issn 0008-543X, 10 p.Article

Immunotherapy (APC8015, Provenge®) targeting prostatic acid phosphatase can induce durable remission of metastatic androgen-independent prostate cancer: A Phase 2 trialBURCH, Patrick A; CROGHAN, Gary A; GASTINEAU, Dennis A et al.The Prostate. 2004, Vol 60, Num 3, pp 197-204, issn 0270-4137, 8 p.Article

Intratumoral administration of a 1,2-dimyristyloxypropyl-3-dimethylhydroxyethyl ammonium bromide/dioleoylphosphatidylethanolamine formulation of the human interleukin-2 gene in the treatment of metastatic renal cell carcinomaGALANIS, Evanthia; BURCH, Patrick A; OKUNO, Scott H et al.Cancer. 2004, Vol 101, Num 11, pp 2557-2566, issn 0008-543X, 10 p.Article

A Phase II study of high-dose paclitaxel in patients with advanced neuroendocrine tumorsANSELL, Stephen M; PITOT, Henry C; BURCH, Patrick A et al.Cancer. 2001, Vol 91, Num 8, pp 1543-1548, issn 0008-543XArticle

Older versus younger patients with metastatic adenocarcinoma of the esophagus, gastroesophageal junction, and stomach: A pooled analysis of eight consecutive North Central Cancer Treatment Group (NCCTG) trialsJATOI, Aminah; FOSTER, Nathan R; EGNER, James R et al.International journal of oncology. 2010, Vol 36, Num 3, pp 601-606, issn 1019-6439, 6 p.Article

Prostate-Specific Antigen Progression Predicts Overall Survival in Patients With Metastatic Prostate Cancer: Data from Southwest Oncology Group Trials 9346 (Intergroup Study 0162) and 9916HUSSAIN, Maha; GOLDMAN, Bryan; BURCH, Patrick A et al.Journal of clinical oncology. 2009, Vol 27, Num 15, pp 2450-2456, issn 0732-183X, 7 p.Article

Predictors of survival from urachal cancer : A mayo clinic study of 49 casesMOLINA, Julian R; FERNANDO QUEVEDO, J; FURTH, Alfred F et al.Cancer. 2007, Vol 110, Num 11, pp 2434-2440, issn 0008-543X, 7 p.Article

A phase IB study of the pharmacokinetics of gemcitabine and pemetrexed, when administered in rapid sequence to patients with advanced solid tumorsDY, Grace K; SURI, Ajit; RUBIN, Joseph et al.Cancer chemotherapy and pharmacology. 2005, Vol 55, Num 6, pp 522-530, issn 0344-5704, 9 p.Article

Birt-Hogg-Dube Syndrome: an autosomal dominant disorder with predisposition to cancers of the kidney, fibrofolliculomas, and focal cutaneous mucinosisLINDOR, Noralane M; HAND, Jennifer; BURCH, Patrick A et al.International journal of dermatology. 2001, Vol 40, Num 10, pp 653-656, issn 0011-9059Article